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http://dx.doi.org/10.1016/j.fjs.2012.Summary Hypertriglyceridemia can induce repeated pancreatitis, which may lead to life-
threatening complications that are very difficult to cure. The exact mechanism is unclear,
but it is believed to involve increased concentrations of chylomicrons in the blood. We report
the case of a man aged 26 years with recurrent pancreatitis related to hypertriglyceridemia.
The cause of his hypertriglyceridemia was diagnosed as familial. He had experienced repeated
pancreatitis since he was 18 years old, and the attack frequency in the previous 2 years had
increased from once per 3 months to once per 1.5 months. He had received diet modification,
medication, and even apheresis, but the effects were not satisfactory. He finally underwent
laparoscopic mini-gastric bypass surgery as a mode of metabolic surgery on August 1, 2011.
His triglyceride level decreased rapidly after the surgery. This result indicates that gastric
bypass surgery may be applied not only to bariatric surgery but may also be used as a treatment
option for patients with intractable hypertriglyceridemia-related pancreatitis.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Gallstones and excessive alcohol consumption are the two
main causes of pancreatitis, accounting for 80e90% of allg-Kuo Road, 330 Taoyuan,
@yahoo.com.tw (W.-J. Lee).
ight ª 2012, Taiwan Surgical Asso
08.002cases.1 The remaining 10e20% of pancreatitis cases have
various causes, including drugs, trauma, and infection.1 In
up to 7% of all cases of pancreatitis, hypertriglyceridemia
or chylomicronemia is the underlying cause.2
Hypertriglyceridemia is often caused and exacerbated
by uncontrolled diabetes mellitus, obesity, and sedentary
habits. Genetic disorders are also some of the known cau-
ses. Removal of the offending medications, lifestyleciation. Published by Elsevier Taiwan LLC. All rights reserved.
0400
800
1200
1600
2000
2400
2800
3200
3600
4000
4400
4800
10th, June
1st,
 July
3rd, July
7th
, July
29th, July
30th, July
31st, July
1st,
 August
2nd,
 A
ugus
3rd, Augus
4th, August
8th, A
ugust
18th, Augu
26th, Augu
27th, Augu
T
G
 (
m
g
/d
l)
TG (mg/dl)
Apheresis
Pancreatitis attack
Diet control before
operation
Surgery
188 S.-Y. Hsu et al.modification, and drug treatment should be considered in
patients with hypertriglyceridemia. Apheresis is also
proposed for serum triglyceride (TG) removal in the treat-
ment and prevention of hypertriglyceridemia-induced
pancreatitis.2
Metabolic surgery, defined as surgery aimed at anatomic
and functional changes to treat metabolic disorders,3 has
been proposed as an effective treatment for resolving
hypertriglyceridemia. The jejunoileal bypass was the first
bariatric surgery that resulted in a significant reduction in
plasma lipids. A partial ileal bypass was then proposed as
a treatment option for hyperlipidemia without a bariatric
effect.4 Recently, a gastric bypass has become the most
commonly performed bariatric surgery and it is highly
effective in the resolution of hyperlipidemia. Therefore,
the gastric bypass should be a treatment option for obese
patients with hypertriglyceridemia-induced pancreatitis.
In this study, we report the first case of laparoscopic
mini-gastric bypass (LMGB) as a means of metabolic surgery
for the treatment of intractable hypertriglyceridemia-
related pancreatitis.t t st st st
Date
Figure 1 Triglyceride trends of the patient in 2011.2. Case report
A man 26 years of age with a medical history of hyper-
triglyceridemia, which began at the age of 10, presented
with recurrent episodes of pancreatitis that started at the
age 18. His TG level was typically in excess of 500 mg/dL,
and it had previously exceeded 4000 mg/dL. He did not
smoke, rarely consumed alcohol, and was not taking medi-
cations that could result in pancreatitis. A clinical diagnosis
of hypertriglyceridemia-related pancreatitis was made.
Although the patient remained on strict diet control and
medication, he had been admitted to hospitals more than
20 times for pancreatitis attacks since the age of 18. He
once received plasmapheresis and double filtration from
July 1, 2011, to July 5, 2011, for hypertriglyceridemia. His
TG level was reduced to approximately 600 mg/dL but
rebounded 3 weeks later (Fig. 1). He was finally referred to
Min-Sheng Hospital in Taoyuan city, Taiwan, for metabolic
surgery.
He experienced no acute attacks while visiting our
clinic, but a number of non-enhanced computed tomog-
raphy (CT) scans disclosed sequelae of pancreatitis (Fig. 2).
We did not arrange contrast-enhanced CT scans because he
had a history of anaphylactic shock status post-
cardiopulmonary resuscitation after contrast injection. The
physical examination revealed an ovoid abdomen without
tenderness. His body mass index (BMI) was 37.1 kg/m2. His
laboratory data were as follows: TG, 3884 mg/dL; low-
density lipoprotein, 116 mg/dL; high-density lipoprotein,
25 mg/dL; total cholesterol, 400 mg/dL; amylase, 38 U/L;
lipase, 167 U/L; and hemoglobin A1C, 5.6%. A gastric bypass
as a means of metabolic surgery for both obesity and high
TG levels was suggested. Preoperative preparation,
including psychological assessment, was made.
He underwent LMGB as a mode of metabolic surgery on
August 1, 2011. LMGB, first reported by Rutledge, is
a modification of Mason’s loop gastric bypass with a long
lesser curvature tube from the antrum to the angle of His
(outer diameter 1e2 cm).5 A loop gastroenterostomy wascreated with the small bowel about 200 cm distal to the
ligament of Trietz in an antecolic position (Fig. 3).5 He
started to sip water on postoperative Day 2 and recovered
without incidents. He was discharged from the hospital on
postoperative Day 7 in a stable condition. Approximately 1
month after the operation, the follow-up laboratory data
disclosed that his TG level had decreased to 327 mg/dL
(Fig. 1). He also had a body weight loss of 17.8 kg. His BMI
decreased from 37.1 to 31.7 kg/m2.
3. Discussion
Hypertriglyceridemia is the most common cause of acute
pancreatitis after gallstones and alcohol consumption.2 The
causes of hypertriglyceridemia can be primary (familial) or
secondary (e.g., insulin resistance, hypothyroidism, drugs,
pregnancy). The exact mechanism of hypertriglyceridemia-
related pancreatitis is unclear. Chylomicrons, which are TG-
rich lipoprotein particles, are believed to be responsible for
pancreatic inflammation.2 However, hypertriglyceridemia-
related pancreatitis rarely occurs if TG levels are lower
than 500 mg/dL. People with hypertriglyceridemia-related
pancreatitis usually have TG levels exceeding 1000 mg/dL.
To treat hypertriglyceridemia, the initial methods
include lifestyle modification and use of drugs (e.g.,
fibrates, nicotinic acid). The rate of plasma TG response to
diet and weight loss is approximately 25%, with marked
variation among patients. Fibrates can reduce TG levels by
as much as 50%, and daily consumption of up to 3 g of
nicotinic acid (niacin) can lower TG levels by as much as
45%.6
Apheresis for high TG levels was first reported in 1978 to
treat severe diabetic hypertriglyceridemia.7 This procedure
can remove chylomicrons directly in the acute stage or be
implemented as a chronic prophylaxis at 4-week intervals
Figure 2 Non-enhanced preoperative computed tomography: (A) axial view showed a homogeneously enlarged pancreatic gland
with adjacent fat necrosis in the tail area; (B) coronal view revealed inflammation extending into the left lower area of the
abdomen. PZ pancreas.
Hypertriglyceridemia-induced pancreatitis 189for recurrent pancreatitis due to severe primary hyper-
triglyceridemia unresponsive to drug and diet adjustment.2
One series of seven patients with an average TG level of
1406 mg/dL had a 41% decrease in TG levels after one
plasma exchange session.8 Nevertheless, the effect of
apheresis is transient, and repeated procedures may be
needed. In our patient, the TG level rebounded to almost
4000 mg/dL approximately 3 weeks after apheresis.
Decreased lipoprotein lipase (LPL) activity is also
a prominent cause of hypertriglyceridemia. One study found
that enhancing LPL activity by using insulin and heparin
reduced TG levels and appeared to improve pancreatitis.2
For patients with repeated pancreatitis due to hyper-
triglyceridemia, metabolic surgery for hyperlipidemia has
also been proposed. The first partial ileal bypass was per-
formedspecifically for the reductionof plasma lipids in 1963.4
The partial ileal bypass differs from the jejunoileal bypass
performed between 1950 and 1970. The jejunoileal bypass
consists of anastomosis of the proximal 40 cm of the jejunum
with the distal 4 cm of the ileum. With more than 90% of theFigure 3 Laparoscopic mini-gastric bypass (schematic view).small intestine bypassed, the therapeutic goal is weight loss,
and lipid reduction is an accompanying benefit.4 However,
this procedure has been abandoned because of long-term
nutritional adverse events. A partial ileal bypass sacrifices
only the distal 200 cm of the small intestine, or one-third of
the small intestinal length. The operation lowers both
cholesterol and TG levels but it does not result in significant
body weight loss compared with other bypass surgeries.4
Gastric bypass is the most commonly performed bari-
atric surgery today. In our previous study, a simplified
gastric bypass, LMGB, was demonstrated to have a low risk
and acceptable efficacy compared with a laparoscopic
Roux-en-Y gastric bypass.5
The rising prevalence of obesity is associated with the
increasing prevalence of obesity comorbidities, including
type 2 diabetes, hypertension, hyperlipidemia/hyper-
triglyceridemia, and obstructive sleep apnea syndrome. In
1991, the National Institutes of Health established guide-
lines for the surgical therapy of morbid obesity (BMI 40, or
BMI 35 with significant comorbidities).9 By modifying the
anatomy of the gastrointestinal tract and affecting hormone
(e.g., ghrelin) secretion, bariatric surgery, as a form of
metabolic surgery, helps obese patients to lose body weight
and improves their obesity-related comorbidities. Recently,
metabolic surgery has also been proposed as a treatment
option for diabetes in nonmorbid obese patients.10
In our patient, hypertriglyceridemia was not related to
obesity. His TG level did not consistently decrease to less
than 500 mg/dL, even after apheresis. As bariatric surgery
would help obese patients improve their metabolic prob-
lems, we performed LMGB to improve our patient’s hyper-
triglyceridemia. His TG level was decreased to less than
500 mg/dL within 3 weeks after surgery. This satisfying
improvement may be related to malabsorption after the
procedure. Thus, when compared with lifestyle modifica-
tion, lipid-lowering agents, and the other aforementioned
methods, surgery may have a better long-term outcome.
In conclusion,we report thefirst Taiwanese case of gastric
bypass surgery to treat intractable hypertriglyceridemia
unrelated to obesity and its potential for preventing recur-
rent pancreatitis. We chose LMGB instead of gastric restric-
tion only (such as laparoscopic adjustable gastric banding)
190 S.-Y. Hsu et al.for its better effect on TG concentrations. This effect may
occur because the bypass surgery decreases TG absorption
from the intestines. In the future, we may utilize gastric
bypass surgeries, such as LMGB, in both non-obese and obese
patients to treat hypertriglyceridemia and related pancrea-
titis. For non-obese patients with hypertriglyceridemia but
no related pancreatitis, we do not suggest bariatric surgery
because of the potential surgical risks. Furthermore, we can
compare the results with those of partial ileal bypass, which
typically has no obvious effect on body weight. However,
determining the type of bypass surgery that may lead to the
optimal outcome will require further investigation.References
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